MedTrace Logo

Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)

NCT01911078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this clinical investigation is to determine the effects of renal sympathetic denervation on insulin resistance and muscle sympathetic nerve activity in patients with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

PROCEDURE

Renal Denervation

Renal artery ablation with the EnligHTN™ Renal Denervation System.

DEVICE

EnligHTN™ Renal Denervation System.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01911078 on ClinicalTrials.gov